-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-08-14
A 2024 Advanced Science study identifies Kupffer-cell TMEM16F, rather than lymphocyte-expressed TMEM16F, as a key determinant of protection against Listeria monocytogenes. Its findings connect calcium-activated lipid scrambling and plasma-membrane repair with control of liver injury, inflammation, and metabolic disruption.
-
Hoechst 33342/PI Double Staining Kit for RCC
2026-08-13
Build a practical RCC treatment-response workflow around dual readouts of chromatin condensation and membrane damage. This guide shows how to apply the Hoechst 33342/PI Double Staining Kit to syringin–sunitinib studies, quantify three cell-state patterns, and troubleshoot misleading fluorescence.
-
EdU Imaging Kits for RCC Drug-Response Studies
2026-08-13
EdU Imaging Kits (HF488) convert S-phase DNA synthesis into a direct, quantitative readout for evaluating syringin, sunitinib, and combination responses in renal cell carcinoma models. Their antibody-free click-chemistry workflow supports both fluorescence imaging and flow cytometry while preserving cell morphology and antigen-accessible epitopes.
-
FPH1 (BRD-6125) Hepatocyte Workflow Guide
2026-08-12
FPH1 (BRD-6125) supports practical expansion and functional qualification of primary human hepatocytes and iPSC-derived hepatocyte-like cells. This workflow-focused guide combines proliferation, albumin, CYP3A4, and AFP readouts with solvent control, timing, and troubleshooting strategies for more reproducible assays.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-08-12
A 2026 study identified a novel pathogenic FLCN nonsense variant and provided functional evidence that the previously uncertain p.W376R variant is pathogenic in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored FLCN expression and reduced abnormal mTORC1 activation, offering an early, in vitro proof of concept for mRNA-based protein replacement in BHD syndrome.
-
DAPI Nuclear Stain Solution Protocol
2026-08-11
DAPI nuclear stain solution K2402 provides a ready-to-use fluorescent DNA stain for nuclear visualization and endpoint cell viability assessment. It is suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, but its weak cell permeability makes it unsuitable as a primary live-cell imaging stain.
-
HyperScribe T7 High Yield RNA Synthesis Kit Plus
2026-08-11
Build high-output, customizable RNA workflows for mRNA rescue, RNA vaccine synthesis, antisense RNA production, and labeled probes. The HyperScribe™ T7 High Yield RNA Synthesis Kit Plus combines T7-driven transcription with practical options for template design, modified nucleotides, purification, and troubleshooting.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-10
The Hoechst 33342/PI Double Staining Kit uses nuclear Hoechst 33342 and membrane-excluded propidium iodide to support rapid fluorescence-based classification of normal, apoptotic, and membrane-compromised cells. Hoechst 33342 propidium iodide staining is useful for chromatin condensation detection and cell membrane integrity assessment, but signal patterns should not be treated as a standalone diagnostic of cell-death mechanism.
-
Ferroelectric–Liquid Metal Artificial Photoreceptor
2026-08-09
The reference study introduces an azo-polymer-grafted liquid-metal nanoparticle composite embedded in a P(VDF-TrFE) ferroelectric matrix to create an artificial photoreceptor with visible-to-infrared sensitivity and biomimetic visual adaptation. In retinal degeneration models, the implant restored light responses and showed stable in vivo integration, supporting ferroelectric hybrid materials as candidates for broad-spectrum retinal prostheses.
-
GPR107 Deficiency and Diabetic Nephropathy
2026-08-08
Xu et al. identify GPR107 as a regulator of podocyte collagen IV homeostasis in diabetic nephropathy, linking defective AT1R endocytosis to calcium-dependent CREB activation and extracellular matrix remodeling. The study combines patient tissue, diabetic mouse models, and high-glucose podocyte experiments to explain how GPR107 loss may worsen glomerular basement membrane injury.
-
Fluo-4 AM for Retinal Bioelectronics
2026-08-07
Fluo-4 AM provides a practical fluorescent calcium indicator readout for testing how photoresponsive retinal implants influence living neural cells. This article connects intracellular calcium concentration measurement with the adaptation and photoelectric behavior reported in a new ferroelectric-liquid metal retinal prosthesis study.
-
α-Bungarotoxin for Precision Nicotinic Receptor Blockade in
2026-08-07
α-Bungarotoxin empowers researchers with high-affinity, selective blockade of α7 nicotinic acetylcholine receptors, enabling precise dissection of cholinergic signaling and necroptosis in both neuroscience and placental models. Recent studies demonstrate its pivotal role in unraveling non-neuronal cholinergic pathways, particularly in disease models like preeclampsia. APExBIO’s reagent ensures reproducibility and clarity in mechanistic experiments.
-
DAPI (hydrochloride): Precision DNA Visualization in Cancer
2026-08-06
DAPI (hydrochloride) stands out as a high-specificity DNA stain optimized for advanced imaging, flow cytometry, and chromatin analysis—even in challenging tumor microenvironments. Learn protocol optimizations, troubleshooting strategies, and how recent mechanobiology insights directly inform assay design.
-
Heparin Sodium: Glycosaminoglycan Anticoagulant in Research
2026-08-06
Heparin sodium from APExBIO empowers advanced modeling of blood coagulation and anti-factor Xa activity in thrombosis research. This article details protocol enhancements, innovative delivery strategies, and troubleshooting tactics to maximize experimental reproducibility.
-
IDH2-Driven Metabolic Reprogramming and HIF-1α in Colorectal
2026-08-05
This article examines how increased IDH2 expression in colorectal cancer cells drives metabolic reprogramming, promoting tumor progression via stabilization of HIF-1α. The study highlights the interplay between TCA cycle disruption, α-ketoglutarate accumulation, and hypoxia signaling, offering mechanistic insights for targeted metabolic interventions.